Assertio Reports Third Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. RCKT
6. CRBU
7. SKYD
8. BBIO
9. CRWV
10. OPCH

Go back to Assertio Reports Third Quarter 2020 Financial Results

Assertio Therapeutics (ASRT) Misses Q3 EPS by 10c, Revenues Beat

November 6, 2020 6:17 AM EST

Assertio Therapeutics (NASDAQ: ASRT) reported Q3 EPS of ($0.09), $0.10 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $34.57 million versus the consensus estimate of $32.5 million.

Reported Net Product Sales of $34.3 MillionNon-GAAP Net Product Sales of $33.7 Million; Increased 21.4% over Pro-Forma Second Quarter 2020Non-GAAP Net Product Sales Consistent with Pro-Forma Prior Year Quarter Despite COVID-19 Related Sales Disruptions and Effects of Sales Force IntegrationProvides Updated Outlook for Remainder of 2020

We are proud of what we have achieved so far this year, as we... More